Target intelligence / Profile preview

SOS response pathway (SOS response)

Target
SOS response
Molecular classification
Transcription factor, Enzyme, DNA-binding protein, ATPase
01

Overview

The SOS response is a global regulatory network in bacteria that is activated in response to significant DNA damage, such as that caused by the mutagenic heterocyclic amine Trp-P-1 (3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole) (Sugimura et al., 1977, PNAS). This pathway is primarily controlled by two key proteins: LexA, a repressor that keeps SOS genes silenced under normal conditions, and RecA, which senses DNA damage by binding to single-stranded DNA (Baharoglu & Mazel, 2014, Nature Reviews Microbiology). Upon activation, RecA facilitates the autocatalytic cleavage of LexA, leading to the rapid expression of genes involved in DNA repair, cell cycle arrest, and error-prone translesion synthesis (Bell & Kowalczykowski, 2016, Annual Review of Biochemistry). While the SOS response is a survival mechanism, its error-prone nature is a major driver of genetic diversity and the evolution of antibiotic resistance in bacterial populations. Trp-P-1 specifically induces this pathway by forming DNA adducts that stall replication forks, creating the single-stranded DNA gaps required for RecA activation. In drug discovery, components of the SOS response, particularly RecA, are investigated as therapeutic targets to prevent the emergence of resistance and to potentiate the activity of DNA-damaging antibiotics (Nautiyal et al., 2014, Journal of Medicinal Chemistry). Inhibiting this pathway could theoretically suppress the adaptive mutations that allow pathogens to survive clinical treatment.

Other names
LexA-RecA pathwayDNA damage-inducible (DDI) responseSOS repair systemBacterial SOS response
02

Mechanism of action

Inhibition of RecA-mediated LexA cleavage; inhibition of RecA filament formation on single-stranded DNA; blockade of LexA repressor dissociation from operator sites.

03

Biological functions

DNA repairMutagenesisCell cycle arrestHorizontal gene transferTranslesion synthesis
04

Disease associations

InfectionAntibiotic resistanceCarcinogenesis
05

Safety considerations

Potential cross-reactivity with human orthologs such as RAD51Interference with essential homologous recombination processesPotential to increase horizontal gene transfer if inhibition is incomplete
06

Interacting drugs

Suramin

3 more in the full profile.

07

Biomarkers

RecA expression levelsLexA cleavage productsumuC/D gene expressionsulA expression

Beyond the preview

Go deeper on SOS response pathway (SOS response).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SOS response pathway (SOS response).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call